The groundbreaking approach of the medication represents a exciting breakthrough in the handling of the condition. Unlike existing therapies, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide793650.blog-kids.com/42430358/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment